Picture of Oruka Therapeutics logo

ORKA — Oruka Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapNeutral

Brief: Arca Biopharma Enters Into Amendment On Demand Sales Agreement With Jonestrading Institutional Services

July 14 (Reuters) - ARCA Biopharma Inc  ABIO.O :
    * ARCA BIOPHARMA - ENTERED INTO AMENDMENT NO. 8 TO CAPITAL
ON
DEMAND SALES AGREEMENT WITH JONESTRADING INSTITUTIONAL SERVICES
    * ARCA BIOPHARMA - AMENDMENT INCREASED MAXIMUM OFFERING
VALUE OF
SHARES WHICH CO MAY ISSUE & SELL FROM TIME TO TIME TO $32.4
MILLION
    * ARCA BIOPHARMA - BELIEVES CASH & CASH EQUIVALENTS WILL BE
SUFFICIENT TO FUND OPERATIONS  THROUGH END OF Q3 2021

Source text (https://bit.ly/2OCrZpr)
Further company coverage:  ABIO.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Oruka Therapeutics

See all news